CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference

BOSTON, July 30, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company's Management will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference, to be held in Boston, MA, and participate in one-on-one investor meetings. Presentation Details Format: Fireside Chat Date: Tuesday, August 13, 2024 Time: 12:30 PM ET Webcast Link: https://wsw.com/webcast/canac ...